Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
MARINUS PHARMACEUTICALS, INC. (MRNS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/06/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.4% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.6% stake in Marinus Pharmaceuticals, Inc. |
| 11/14/2022 |
SC 13G
| Point72 Asset Management, L.P. reports a 7.1% stake in Marinus Pharmaceuticals, Inc. |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/20/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.6% stake in Marinus Pharmaceuticals, Inc. |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Lion Point Capital, LP reports a 7.7% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/20/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/13/2019 |
SC 13G
| Boxer Capital, LLC reports a 6% stake in Marinus Pharmaceuticals, Inc. |
| 10/07/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 7.6% stake in Marinus Pharmaceuticals, Inc. |
| 02/05/2018 |
SC 13G
| JENNISON ASSOCIATES LLC reports a 6.7% stake in Marinus Pharmaceuticals, Inc. |
| 01/22/2018 |
SC 13G
| PRUDENTIAL FINANCIAL INC reports a 6.7% stake in MARINUS PHARMACEUTICALS, INC. |
| 09/28/2017 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. reports a 14.4% stake in Marinus Pharmaceuticals, Inc. |
| 08/08/2017 |
SC 13G
| EcoR1 Capital, LLC reports a 12.2% stake in Marinus Pharmaceuticals, Inc. |
| 07/18/2017 |
SC 13G
| Granite Point Capital Management, L.P. reports a 9.8% stake in Marinus Pharmaceuticals, Inc. |
| 07/17/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/06/2016 |
SC 13G
| SPHERA FUNDS MANAGEMENT LTD. reports a 6% stake in MARINUS PHARMACEUTICALS, INC. |
|
|